M. Sieprawska-Lupa, P. Mydel, K. Krawczyk, K. Wojcik, M. Puklo, B. Lupa, P. Suder, J. Silberring, M. Reed, J. Pohl, W. Shafer, F. McAleese, T. Foster, J. Travis and J. Potempa, “Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus-Derived Proteinases,” Antimicrobial Agents and Chemotherapy, Vol. 48, No. 12, 2004, pp. 4673-4679. doi:10.1128/AAC.48.12.4673-4679.2004

has been cited by the following article:

• TITLE: Susceptibility of Staphylococcus aureus Isolates Causing Bloodstream Infection to the Antimicrobial Peptide LL-37

  AUTHORS: Sinead McNicholaswhj, Hilary Humphreys, Deirdre Fitzgerald Hughes

  KEYWORDS: Staphylococcus aureus; Bloodstream Infection; LL-37

  JOURNAL NAME: Open Journal of Medical Microbiology, Vol.3 No.1, March 13, 2013

  ABSTRACT: Both bacterial and host factors contribute to complicated bloodstream infection (BSI) caused by Staphylococcus aureus including methicillin-resistant S. aureus (MRSA). One bacterial factor that may affect the persistence of S. aureus in complicated BSI is reduced susceptibility to the innate immune defence peptide LL-37. LL-37 susceptibility among S. aureus isolates causing uncomplicated and complicated BSI was investigated. Following incubation with 2.5 μg/ml LL-37 for 1 h, the mean percentage survival was 67.6% and 74.9% for isolates causing uncomplicated and complicated BSI, respectively. Reduced LL-37 susceptibility may contribute to the persistence of S. aureus in complicated BSI.